{
  "question": "I am trying to target the second exon of a gene with the following sequence using spCas9:\n\nATGTGTGCCTGCGGGATACTTTTGACTTTTACTTTGCTTTTGCATTTTCTTGGTGTTCACTCAATGAATCCTCTGTTTCCAAGCGCATCCAGGGGCATGAAAGTGTCTAAGTCTGTTCCTGCTGAGGGCAACAGGAGAGCAAAATACGGCAAGAATGTGCTGTCAGCATCACTGTTATCCGGAGACATACAGTCCAGAAGGGCGATCAAGGATGCGATTGAACCTCACGATTACATGATTTCCATATACAAGACCTTTTCAGCGGCTGAAAAACTGGGACTGAACGCGAGTTTTTTCCGCTCGTCTAAAGCAGCAAACACCATCACGAGCTTTGTGGACGAGGGTCAAG^GTTAGTTATTTCTACTTATACAAGCAACAGTGATTTCAAACGCACACGTACTGATTCTATATTGGTACTCACAGGGAAAAAAAAAAAAAAAACATTTGTATACAATTCAAACAACTCTTAAAGGAATACAGTCAAATGTGTCAGTGAACAGATGGAAACAAAGCATTTTGAATATTAGGCCTATATCATCTATGATACTGCGGAAAATCTTCAAGAAATCTTTTTCCCCTAATAGTAAAAATAATGACAACAATATATGTATAACATTATACACTTCTGTTTACAATCTTGCATAAAATAAGTTGTGTTTGCATCAAAGTGTGTATACATGCACTGTCCATTTCAAATATTTTTTATTGGAATGTGTAGGAATTTTCACGATGTAGGCAGGTTATTATCACTATAAAGTGCCTTAGATGTCCCACAAGATTGAATCAGTCCCATATGAGCATAATGCGAAATTGATGTTTTAATATGATTGGTTAAACTTGTACACACATGCAGGTAGAATTATGAGTGTTTTGAAACATGTTTTTGCCAATTATTGCCATAGTCTTTTATTGAATGGATGTGATTTTGCCATGTCCCACACACTGCACAGCCAAGTTCAGTAAGTCTAAAAAGTAGCTAAATTAGATAAATTTTTTTTAAATGTTTAAGTATTCTTTCTATTCTTACAGTTATTTTGAAAACTAAATCATTTTTATAACTTTTATTTTTTTATTCTTTTATAATATTATTAATCATTTTGCACGAGTCTTTGAGTTTGCTGTCCACCCTGTCATGATGTAGTAAATCCCCTTTAAGAAACCCTCTGATGTACTCATTGGCATCCCCATGCCTATTTTGCTTTTCTTCAGAGGAGGTTAAAAAAACTGATGTGCACACATTAAATATCTACATATATGTTTCCTATTTTTCATCATATTGTGTTTGAAACCGAATGTGGTCAAGCTTAACATGTCCACCCTGTCATAGTAAAATATTAATTAATATAAAAAATTCGGAAATCAAAGATAGCTTTTAAACTGTATACAAAGAGCTTAAATAAGGAAACACTTTACCAGCTGCAGGTTCAACCTGTGTTAAATAAATGCTATCTTTAGCCAAAAATGTCCTCCTTGTTATTGTCCACCCTTTCACAAATCCTTCCTTGGGTGGACATATGCATCGTTATTGACACTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTTGTTAATCAGCTAATGTTTTATTATGGTACATCACATACATACTACACCAGTAGATGCAATACATAAGTGGACAATACAAATCTTTTGGCAATATTTATCTCAGTCTATATAAAGAATATCCTTTTAAAGTCCATATAAGGCAGCTCATTGACTGTTTGAAATTAAAATACATTATTTATCCTATTCTGGAAAAGAAAAAATATGATACATTTGTGCGTTGATGGATTTGAAACCACACTGGACTGAACTAATTTGAACTTTTAATTTCAATTCACTACAACTTCTATGTTAAGCTGCTTAGACACAATTTACATTACAGGTGTCAAATCCAGTTTCTTAAGAGCCACAGCTCTGCACAGTTTAGGGTTAACCCTAATTAAACACACCTGATCAAACTAATTGAGTCCTTCAGGCTTGTTTGATACCTACAGGTAGGTTTGTTAAAGCAAGGTTGGAACTAAATTGTGCAGAGCTGCGGCCCTTCAGGAACTAGATTTGACACCTAATTTACATTATGGAAACGCTATAGAAATAAAGATAAATTGAATTGAATAGATTTTTCTCCTCCAAAACACTATATATAAAAATACTAATTAGCAAATGCTAGTATTAGAAAAAAAAATTAGAACCTAGCTTTAAAAACTTTAGCATAATGAAAGAAACAGAGACACAAGACAGAAATAAATTTCAACATATGTCACCTTAATTAGTTAAAAACGAGTTCTCGATCTGCACATGCCATAACAGATATTGTAAATTTTGTGGATGCAGATCTAGTGTCAACAAGCATCTGTTCTCTTTGTTTCAG^ATGACCATTTGAACTCTCCACTTTGGAGACAGAAATATTTATTCGACGTATCAACGCTTTCTGAAAATGTGGAGATCCTGGGTGCCGAACTGAGGATTTACACAAAGATCTCCGGAAGCTTCCGCGCATCTGAAACCGGTCCTGTGGAAATACAGCTTCTCTCCTGCCAGTCGCACACTGTCCTTGATTCACAAACTTTGGATCTGGAGGATGCACATAAACCAAAATGGGAAGTTTTCGACGTCTGGGAGATTTTTAAGGAACGTCAGCACCACTCTCATGGCACCCGCTTCTGTTTAGAGCTCAGGGCCACACTGGATAATCCAGAGAGAGAAATTGATTTGCAATATCTTGGATTTCACAGACATGGCCGCCCGCAACTGAAGAAAGCCATACTGGTTGTTTTCACAAGGTCAAAAAAGAGGCAAAGTCTTTTTTATGAAAAAAGAGAGAAGATCAAGCTATGGGGTCTGGATAGTATTGGTAAGGAAAGAAGATCCCACTCGAAAACCCGCCGGAGCAGACGGACTGCTCTACCCAATCGCCATGGCAAGAGACATGGTAAAAAGTCAAAATCTAGATGCAGCAAAAAGCCACTGCATGTCAATTTCAGAGAGCTGGGTTGGGACGATTGGGTCATCGCTCCATTAGATTATGAGGCTTATCACTGTGAGGGCATGTGTGACTTTCCCCTCCGATCTCACCTGGAACCAACCAATCATGCCATCATACAAACTCTAATGAACTCAATGAACCCCAGCAACATGCCACCCAGCTGTTGCGTCCCCTCCAAACTCAGTCCCATTAGCATCTTGTACATTGACGCAGGAAATAATGTTGTGTACAAGCAGTATGAAGACATGGTAGTGGAGTCCTGCGGCTGCAGATGA\n\nThe first exon is the region before the first caret. The region between the two carets is the intron, and the region after the second caret is the second exon.  Which of the following would be a suitable target sequence to use for my sgRNA? I do not have data for the entire genome, so use your best guess as to what would have the fewest potential off-target hits.\n\nAnswer Choices:\nA. AGCGGTTTACTGAGACCCGG(TGG)\nB. TCCGGCGGGTTTTCGAGTGGG\nC. TTCATGCCCCTGGATGCGCT(TGG)\nD. CAGGACCGGTTTCAGATGCG(CGG)\nE. GCATCTGAAACCGGTCCTG(TGG)\nF. GGAAGCAATCCTCCGAACGT(TGG)\nG. ACGTTGCGAGGACAGAGTCA(AGG)\nH. CCCTTTCACAAATCCTTCCT(TGG)\nI. TTCACCCGCACCTTGAACGG(AGG)\nJ. CTTTCTTTCTTTCTTTCTTTC(TTT)\nK. CTGCTCTACCCAATCGCCA(TGG)\nL. TGCCTG(CGG)\nM. TGCAAAGTAGATCGAGATGG(AGG)\nN. ACAGTCCAGAAGGGCGATCA(AGG)\nO. ATG(ACC)\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<9.8>>>.",
  "response_list": [
    "The user wants me to identify the best sgRNA target sequence for the second exon of a given gene, to be used with SpCas9.\n\nHere's a breakdown of the steps:\n\n1.  **Identify the second exon sequence:** The user has clearly demarcated the exons and intron with carets (`^`). The second exon is the sequence *after* the second caret.\n\n2.  **Analyze the answer choices:** Each choice provides a potential target sequence and the Protospacer Adjacent Motif (PAM) in parentheses. For SpCas9, the PAM sequence is typically NGG. The guide RNA sequence is the 20 nucleotides upstream of the PAM.\n\n3.  **Filter for presence in the second exon:** I will go through each answer choice and see if the 20-nucleotide guide sequence is present in the second exon.\n\n4.  **Evaluate sgRNA design principles for the remaining candidates:**\n    *   **Length:** The ideal length for an sgRNA guide sequence is around 20 nucleotides. All the given options are of this length.\n    *   **PAM Sequence:** The protospacer adjacent motif (PAM) for *Streptococcus pyogenes* Cas9 (SpCas9) is NGG, where N can be any nucleotide. The sgRNA sequence itself does not include the PAM. The Cas9 enzyme cuts approximately 3-4 bases upstream of the PAM sequence. I need to verify that the sequence in the exon is followed by the correct PAM.\n    *   **GC Content:** The optimal GC content for an sgRNA is generally between 40-60% to ensure stability without being too rigid.\n    *   **Off-target effects:** Without a full genome, predicting off-target effects is difficult. However, I can make an educated guess by looking for sequences that are less likely to have repeats or simple nucleotide compositions. Extremely repetitive sequences like 'TTTCTTTCTTTCTTTCTTTCTTT' (Choice J) are generally poor candidates due to the high probability of finding similar sequences elsewhere in the genome.\n\n5.  **Step-by-step analysis of each option:**\n\n    *   **Second Exon Sequence:** `ATGACCATTTGAACTCTCCACTTTGGAGACAGAAATATTTATTCGACGTATCAACGCTTTCTGAAAATGTGGAGATCCTGGGTGCCGAACTGAGGATTTACACAAAGATCTCCGGAAGCTTCCGCGCATCTGAAACCGGTCCTGTGGAAATACAGCTTCTCTCCTGCCAGTCGCACACTGTCCTTGATTCACAAACTTTGGATCTGGAGGATGCACATAAACCAAAATGGGAAGTTTTCGACGTCTGGGAGATTTTTAAGGAACGTCAGCACCACTCTCATGGCACCCGCTTCTGTTTAGAGCTCAGGGCCACACTGGATAATCCAGAGAGAGAAATTGATTTGCAATATCTTGGATTTCACAGACATGGCCGCCCGCAACTGAAGAAAGCCATACTGGTTGTTTTCACAAGGTCAAAAAAGAGGCAAAGTCTTTTTTATGAAAAAAGAGAGAAGATCAAGCTATGGGGTCTGGATAGTATTGGTAAGGAAAGAAGATCCCACTCGAAAACCCGCCGGAGCAGACGGACTGCTCTACCCAATCGCCATGGCAAGAGACATGGTAAAAAGTCAAAATCTAGATGCAGCAAAAAGCCACTGCATGTCAATTTCAGAGAGCTGGGTTGGGACGATTGGGTCATCGCTCCATTAGATTATGAGGCTTATCACTGTGAGGGCATGTGTGACTTTCCCCTCCGATCTCACCTGGAACCAACCAATCATGCCATCATACAAACTCTAATGAACTCAATGAACCCCAGCAACATGCCACCCAGCTGTTGCGTCCCCTCCAAACTCAGTCCCATTAGCATCTTGTACATTGACGCAGGAAATAATGTTGTGTACAAGCAGTATGAAGACATGGTAGTGGAGTCCTGCGGCTGCAGATGA`\n\n    *   **A. AGCGGTTTACTGAGACCCGG(TGG):** Not in the second exon.\n    *   **B. TCCGGCGGGTTTTCGAGTGGG:** Not in the second exon.\n    *   **C. TTCATGCCCCTGGATGCGCT(TGG):** Not in the first exon either (I checked just in case). It is from the first exon (`GCGCATCCAGGGGCATGAA`). The reverse complement would be `TTCATGCCCCTGGATGCGC`. Let's re-check the exon sequence. It is in the *first* exon: `TTCATGCCCCTGGATGCGCT` is the reverse complement of `AGGCGCATCCAGGGGCATGA`. The question asks to target the *second* exon. So this is incorrect.\n    *   **D. CAGGACCGGTTTCAGATGCG(CGG):** `...GCATCTGAAACCGGTCCTG...` in the second exon. Let's look for the reverse complement `GCATCTGAAACCGGTCCTG`. No. The forward sequence `CAGGACCGGTTTCAGATGCG` is not in the exon. Let's check the reverse complement of a sequence in the exon. The sequence `GCATCTGAAACCGGTCCTG` is present. Its reverse complement is `CAGGACCGGTTTCAGATGC`. The choice is `CAGGACCGGTTTCAGATGCG(CGG)`. This guide sequence is present as the reverse complement. The PAM `CGG` follows `GCATCTGAAACCGGTCCTG`. The guide would bind to `GCATCTGAAACCGGTCCTG`. So, `CAGGACCGGTTTCAGATGCG` would be the guide RNA, and the sequence on the other strand would be targeted. Let me check the target strand. The exon sequence is given as a single strand. The guide `CAGGACCGGTTTCAGATGCG` would target the complementary strand, and the PAM (`CGG`) needs to be on the non-target strand, adjacent to the protospacer. The sequence in the exon is `GCGCATCTGAAACCGGTCCTGTGGAAATAC`. The guide would be `CAGGACCGGTTTCAGATGCG`. The sequence targeted would be `GCATCTGAAACCGGTCCTGT`. Let's re-examine `E` which seems more direct.\n    *   **E. GCATCTGAAACCGGTCCTG(TGG):** The sequence `GCATCTGAAACCGGTCCTG` is present in the second exon. It is followed by `TGG`. `TGG` is a valid PAM sequence for SpCas9 (NGG). The guide RNA sequence would be `GCATCTGAAACCGGTCCTG`. The length is 20 nt (it's actually 19, let me recount `GCATCTGAAACCGGTCCTG` is 19). Guide RNAs can be 17-23 nts. Let's re-read. Ah, `The target sequence length must be optimal. 17-23 is the ideal range`. So 19 is fine. What is the GC content? G=6, C=4. Total GC=10. Content = 10/19 = 52.6%. This is within the optimal 40-60% range. This looks like a very strong candidate.\n    *   **F. GGAAGCAATCCTCCGAACGT(TGG):** Not in the second exon.\n    *   **G. ACGTTGCGAGGACAGAGTCA(AGG):** Not in the second exon.\n    *   **H. CCCTTTCACAAATCCTTCCT(TGG):** This sequence is in the *intron*, not the second exon.\n    *   **I. TTCACCCGCACCTTGAACGG(AGG):** Not in the second exon.\n    *   **J. CTTTCTTTCTTTCTTTCTTTC(TTT):** This is present in the intron `TTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTT`. Highly repetitive sequences are poor choices for sgRNAs because of the high likelihood of off-target effects. Also the PAM `TTT` is not the canonical NGG for SpCas9.\n    *   **K. CTGCTCTACCCAATCGCCA(TGG):** The sequence `CTGCTCTACCCAATCGCCA` is present in the second exon. It is followed by `TGG`. `TGG` is a valid PAM. The length is 19 nt. GC content: C=7, G=1. Total GC=8. Content = 8/19 = 42.1%. This is also a strong candidate.\n    *   **L. TGCCTG(CGG):** The guide sequence is too short (5 nt). Optimal length is 17-23 nt. This is a poor choice.\n    *   **M. TGCAAAGTAGATCGAGATGG(AGG):** Not in the second exon.\n    *   **N. ACAGTCCAGAAGGGCGATCA(AGG):** This sequence is in the *first* exon.\n    *   **O. ATG(ACC):** Too short. `ATG` is the start codon of the exon. The PAM `ACC` is not NGG.\n\n**Comparing E and K:**\n\n*   **E. GCATCTGAAACCGGTCCTG(TGG)**\n    *   Present in the second exon: `...GCGCATCTGAAACCGGTCCTGTGG...`\n    *   Guide: `GCATCTGAAACCGGTCCTG` (19 nt)\n    *   PAM: `TGG` (valid)\n    *   GC Content: 52.6% (good)\n    *   Sequence composition: Looks reasonably complex.\n\n*   **K. CTGCTCTACCCAATCGCCA(TGG)**\n    *   Present in the second exon: `...GACGGACTGCTCTACCCAATCGCCATGG...`\n    *   Guide: `CTGCTCTACCCAATCGCCA` (19 nt)\n    *   PAM: `TGG` (valid)\n    *   GC Content: 42.1% (good)\n    *   Sequence composition: Looks reasonably complex.\n\nBoth E and K are good candidates based on the fundamental criteria. Let's re-examine the full exon sequence. Exon 2 starts with `ATGACCATT...`. Targeting the beginning of the exon is often a good strategy for gene knockout.\n\n`E` (`GCATCTGAAACCGGTCCTG`) is located relatively early in the exon.\n`K` (`CTGCTCTACCCAATCGCCA`) is located further downstream.\n\nLet's check the answer choice D again.\n*   **D. CAGGACCGGTTTCAGATGCG(CGG):** This guide sequence would target the opposite strand of the `GCATCTGAAACCGGTCCTG` sequence from option E. Let's look at the DNA.\n    5'-...GCATCTGAAACCGGTCCTGTGG...-3'\n    3'-...CGTAGACTTTGGCCAGGACACC...-5'\n    The guide RNA is complementary to the target strand. The target strand for SpCas9 is the one with the PAM. So the PAM (NGG) is on the non-complementary strand. Let me re-read this, it's a common point of confusion.\n    - \"The PAM is about 2-6 nucleotides downstream of the DNA sequence targeted by the guide RNA\"\n    - \"sgRNAs are complimentary to the strand of DNA opposite of the PAM.\"\n    - \"The target sequence needs to be next to a PAM sequence of NGG ... on the strand opposite from the NGG PAM site\"\n    This means if my target sequence is 5'-...TARGET...-3' and the guide is complementary to this, the PAM must be on the other strand, 3'-...PAM...-5', immediately downstream of the target complement. This is equivalent to saying the PAM is on the target strand immediately downstream of the target sequence. Let's re-verify: \"The PAM sequence, NGG, must follow the targeted region on the opposite strand of the DNA with respect to the region complementary sgRNA sequence.\". Okay, let's draw it out.\n\n    Non-target strand: 5' - [20 nt Guide Sequence] - NGG - 3'\n    Target strand:     3' - [20 nt Target Complement] - NCC - 5'\n    The sgRNA sequence itself matches the non-target strand sequence.\n\n    So, if the given exon sequence is the 5'-3' strand:\n    For **E**: `GCATCTGAAACCGGTCCTG` followed by `TGG`. The sequence `GCATCTGAAACCGGTCCTG` would be the guide RNA sequence. This matches the non-target strand. The PAM `TGG` is present on this strand. This is a valid configuration.\n\n    For **D**: `CAGGACCGGTTTCAGATGCG`. This is the reverse complement of `GCATCTGAAACCGGTCCA` (almost). The option is `CAGGACCGGTTTCAGATGCG(CGG)`. The sequence in the gene is `...GCGCATCTGAAACCGGTCCTG TGG...`. If we use D, the guide RNA is `CAGGACCGGTTTCAGATGCG`. This means the *target strand* contains `GCATCTGAAACCGGTCCTG` which has the `CGG` PAM for `D`. Let's see: `...GCATCTGAAACCGGTCCTG TGG AAATACAGCTT...`. If the guide is `CAGGACCGGTTTCAGATGCG`, the targeted sequence on the other strand would be `GCATCTGAAACCGGTCCT`. The sequence following this on the target strand is GTG, its complement is CAC not CGG. So D is not correct as the PAM doesn't match the actual sequence context.\n\n    Let's re-evaluate all options with this clear rule. The guide sequence in the option is what is synthesized as the RNA, and it matches the non-target strand. The exon sequence given is the non-target strand if it contains 'NGG'.\n\n    **Given sequence (5' -> 3'):**\n    `ATGACCATTTG...CGCGCATCTGAAACCGGTCCTG TGG AAATACAG...ACGGACTGCTCTACCCAATCGCCA TGG CAAGAGAC...`\n\n    *   **A. AGCGGTTTACTGAGACCCGG(TGG):** Not present.\n    *   **B. TCCGGCGGGTTTTCGAGTGGG:** Not present.\n    *   **C. TTCATGCCCCTGGATGCGCT(TGG):** In exon 1.\n    *   **D. CAGGACCGGTTTCAGATGCG(CGG):** Not present in the given orientation. The reverse complement is present but the PAM does not match.\n    *   **E. GCATCTGAAACCGGTCCTG(TGG):** Present in the second exon (`GCATCTGAAACCGGTCCTG`). It is followed by a valid `TGG` PAM. GC content is good (52.6%). Length is 19nt (good). It is located early in the exon.\n    *   **F. GGAAGCAATCCTCCGAACGT(TGG):** Not present.\n    *   **G. ACGTTGCGAGGACAGAGTCA(AGG):** Not present.\n    *   **H. CCCTTTCACAAATCCTTCCT(TGG):** In intron.\n    *   **I. TTCACCCGCACCTTGAACGG(AGG):** Not present.\n    *   **J. CTTTCTTTCTTTCTTTCTTTC(TTT):** In intron and has bad characteristics (repetitive, wrong PAM).\n    *   **K. CTGCTCTACCCAATCGCCA(TGG):** Present in the second exon (`CTGCTCTACCCAATCGCCA`). It is followed by a valid `TGG` PAM. GC content is good (42.1%). Length is 19nt (good).\n    *   **L. TGCCTG(CGG):** Too short.\n    *   **M. TGCAAAGTAGATCGAGATGG(AGG):** Not present.\n    *   **N. ACAGTCCAGAAGGGCGATCA(AGG):** In exon 1.\n    *   **O. ATG(ACC):** Too short, wrong PAM.\n\nWe are left with **E** and **K**. Both are excellent candidates. However, sgRNA design guidelines often suggest targeting a site early in the coding sequence to increase the likelihood of generating a knockout via a frameshift mutation. Choice E, `GCATCTGAAACCGGTCCTG`, is located at nucleotides 70-88 of the second exon. Choice K, `CTGCTCTACCCAATCGCCA`, is located at nucleotides 316-334. Therefore, targeting the site in option E is more likely to result in a non-functional protein. Furthermore, without a full genome, minimizing complexity can be a proxy for minimizing off-target hits. While both E and K appear complex, there isn't a strong reason to prefer one over the other on this basis alone. The key differentiator is the location within the exon. Option E's earlier position makes it a strategically better choice for gene knockout.\n\nFinal check:\n- Is `GCATCTGAAACCGGTCCTG(TGG)` in the second exon? Yes.\n- Is the guide length (19nt) appropriate? Yes, 17-23 is fine.\n- Is the PAM (TGG) correct for SpCas9? Yes, it fits the NGG pattern.\n- Is the GC content (52.6%) appropriate? Yes, 40-60% is ideal.\n- Is it a highly repetitive sequence? No.\n- Is its position in the exon good for knockout? Yes, it's relatively early.\n\nAll checks pass. E is a very strong candidate. I'm confident in this choice.I have identified the sequence of the second exon. I have reviewed the principles of sgRNA design for SpCas9, including the requirement for a downstream NGG PAM sequence, optimal guide length, and GC content. I have systematically evaluated each answer choice by checking if the potential guide sequence is present in the second exon, if it is followed by a valid PAM sequence, and if its length and GC content are appropriate. I have eliminated options that are not in the second exon, that have an incorrect PAM sequence, that are of an inappropriate length, or that are highly repetitive. I have narrowed the possibilities down to two strong candidates, E and K. By considering the principle that targeting the 5' end of a coding sequence is generally preferred for gene knockout experiments, I have determined that E is the more suitable choice as it is located earlier in the exon than K. I have sufficient information to answer the question.\n\n<<<E>>>"
  ],
  "user_prompt_list": [
    "I am trying to target the second exon of a gene with the following sequence using spCas9:\n\nATGTGTGCCTGCGGGATACTTTTGACTTTTACTTTGCTTTTGCATTTTCTTGGTGTTCACTCAATGAATCCTCTGTTTCCAAGCGCATCCAGGGGCATGAAAGTGTCTAAGTCTGTTCCTGCTGAGGGCAACAGGAGAGCAAAATACGGCAAGAATGTGCTGTCAGCATCACTGTTATCCGGAGACATACAGTCCAGAAGGGCGATCAAGGATGCGATTGAACCTCACGATTACATGATTTCCATATACAAGACCTTTTCAGCGGCTGAAAAACTGGGACTGAACGCGAGTTTTTTCCGCTCGTCTAAAGCAGCAAACACCATCACGAGCTTTGTGGACGAGGGTCAAG^GTTAGTTATTTCTACTTATACAAGCAACAGTGATTTCAAACGCACACGTACTGATTCTATATTGGTACTCACAGGGAAAAAAAAAAAAAAAACATTTGTATACAATTCAAACAACTCTTAAAGGAATACAGTCAAATGTGTCAGTGAACAGATGGAAACAAAGCATTTTGAATATTAGGCCTATATCATCTATGATACTGCGGAAAATCTTCAAGAAATCTTTTTCCCCTAATAGTAAAAATAATGACAACAATATATGTATAACATTATACACTTCTGTTTACAATCTTGCATAAAATAAGTTGTGTTTGCATCAAAGTGTGTATACATGCACTGTCCATTTCAAATATTTTTTATTGGAATGTGTAGGAATTTTCACGATGTAGGCAGGTTATTATCACTATAAAGTGCCTTAGATGTCCCACAAGATTGAATCAGTCCCATATGAGCATAATGCGAAATTGATGTTTTAATATGATTGGTTAAACTTGTACACACATGCAGGTAGAATTATGAGTGTTTTGAAACATGTTTTTGCCAATTATTGCCATAGTCTTTTATTGAATGGATGTGATTTTGCCATGTCCCACACACTGCACAGCCAAGTTCAGTAAGTCTAAAAAGTAGCTAAATTAGATAAATTTTTTTTAAATGTTTAAGTATTCTTTCTATTCTTACAGTTATTTTGAAAACTAAATCATTTTTATAACTTTTATTTTTTTATTCTTTTATAATATTATTAATCATTTTGCACGAGTCTTTGAGTTTGCTGTCCACCCTGTCATGATGTAGTAAATCCCCTTTAAGAAACCCTCTGATGTACTCATTGGCATCCCCATGCCTATTTTGCTTTTCTTCAGAGGAGGTTAAAAAAACTGATGTGCACACATTAAATATCTACATATATGTTTCCTATTTTTCATCATATTGTGTTTGAAACCGAATGTGGTCAAGCTTAACATGTCCACCCTGTCATAGTAAAATATTAATTAATATAAAAAATTCGGAAATCAAAGATAGCTTTTAAACTGTATACAAAGAGCTTAAATAAGGAAACACTTTACCAGCTGCAGGTTCAACCTGTGTTAAATAAATGCTATCTTTAGCCAAAAATGTCCTCCTTGTTATTGTCCACCCTTTCACAAATCCTTCCTTGGGTGGACATATGCATCGTTATTGACACTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTTTTGTTAATCAGCTAATGTTTTATTATGGTACATCACATACATACTACACCAGTAGATGCAATACATAAGTGGACAATACAAATCTTTTGGCAATATTTATCTCAGTCTATATAAAGAATATCCTTTTAAAGTCCATATAAGGCAGCTCATTGACTGTTTGAAATTAAAATACATTATTTATCCTATTCTGGAAAAGAAAAAATATGATACATTTGTGCGTTGATGGATTTGAAACCACACTGGACTGAACTAATTTGAACTTTTAATTTCAATTCACTACAACTTCTATGTTAAGCTGCTTAGACACAATTTACATTACAGGTGTCAAATCCAGTTTCTTAAGAGCCACAGCTCTGCACAGTTTAGGGTTAACCCTAATTAAACACACCTGATCAAACTAATTGAGTCCTTCAGGCTTGTTTGATACCTACAGGTAGGTTTGTTAAAGCAAGGTTGGAACTAAATTGTGCAGAGCTGCGGCCCTTCAGGAACTAGATTTGACACCTAATTTACATTATGGAAACGCTATAGAAATAAAGATAAATTGAATTGAATAGATTTTTCTCCTCCAAAACACTATATATAAAAATACTAATTAGCAAATGCTAGTATTAGAAAAAAAAATTAGAACCTAGCTTTAAAAACTTTAGCATAATGAAAGAAACAGAGACACAAGACAGAAATAAATTTCAACATATGTCACCTTAATTAGTTAAAAACGAGTTCTCGATCTGCACATGCCATAACAGATATTGTAAATTTTGTGGATGCAGATCTAGTGTCAACAAGCATCTGTTCTCTTTGTTTCAG^ATGACCATTTGAACTCTCCACTTTGGAGACAGAAATATTTATTCGACGTATCAACGCTTTCTGAAAATGTGGAGATCCTGGGTGCCGAACTGAGGATTTACACAAAGATCTCCGGAAGCTTCCGCGCATCTGAAACCGGTCCTGTGGAAATACAGCTTCTCTCCTGCCAGTCGCACACTGTCCTTGATTCACAAACTTTGGATCTGGAGGATGCACATAAACCAAAATGGGAAGTTTTCGACGTCTGGGAGATTTTTAAGGAACGTCAGCACCACTCTCATGGCACCCGCTTCTGTTTAGAGCTCAGGGCCACACTGGATAATCCAGAGAGAGAAATTGATTTGCAATATCTTGGATTTCACAGACATGGCCGCCCGCAACTGAAGAAAGCCATACTGGTTGTTTTCACAAGGTCAAAAAAGAGGCAAAGTCTTTTTTATGAAAAAAGAGAGAAGATCAAGCTATGGGGTCTGGATAGTATTGGTAAGGAAAGAAGATCCCACTCGAAAACCCGCCGGAGCAGACGGACTGCTCTACCCAATCGCCATGGCAAGAGACATGGTAAAAAGTCAAAATCTAGATGCAGCAAAAAGCCACTGCATGTCAATTTCAGAGAGCTGGGTTGGGACGATTGGGTCATCGCTCCATTAGATTATGAGGCTTATCACTGTGAGGGCATGTGTGACTTTCCCCTCCGATCTCACCTGGAACCAACCAATCATGCCATCATACAAACTCTAATGAACTCAATGAACCCCAGCAACATGCCACCCAGCTGTTGCGTCCCCTCCAAACTCAGTCCCATTAGCATCTTGTACATTGACGCAGGAAATAATGTTGTGTACAAGCAGTATGAAGACATGGTAGTGGAGTCCTGCGGCTGCAGATGA\n\nThe first exon is the region before the first caret. The region between the two carets is the intron, and the region after the second caret is the second exon.  Which of the following would be a suitable target sequence to use for my sgRNA? I do not have data for the entire genome, so use your best guess as to what would have the fewest potential off-target hits.\n\nAnswer Choices:\nA. AGCGGTTTACTGAGACCCGG(TGG)\nB. TCCGGCGGGTTTTCGAGTGGG\nC. TTCATGCCCCTGGATGCGCT(TGG)\nD. CAGGACCGGTTTCAGATGCG(CGG)\nE. GCATCTGAAACCGGTCCTG(TGG)\nF. GGAAGCAATCCTCCGAACGT(TGG)\nG. ACGTTGCGAGGACAGAGTCA(AGG)\nH. CCCTTTCACAAATCCTTCCT(TGG)\nI. TTCACCCGCACCTTGAACGG(AGG)\nJ. CTTTCTTTCTTTCTTTCTTTC(TTT)\nK. CTGCTCTACCCAATCGCCA(TGG)\nL. TGCCTG(CGG)\nM. TGCAAAGTAGATCGAGATGG(AGG)\nN. ACAGTCCAGAAGGGCGATCA(AGG)\nO. ATG(ACC)\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<9.8>>>."
  ],
  "system_message": ""
}